Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line

被引:83
作者
Chang, JS
Liu, HW
Wang, KC
Chen, MC
Chiang, LC
Hua, YC
Lin, CC
机构
[1] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan
关键词
antiviral assay; chronic B hepatitis; HepG2; Polygonum cuspidatum; polymerase chain reaction; TaqMan;
D O I
10.1016/j.antiviral.2004.12.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic hepatitis B virus (HBV) infection is endemic in Asia and its consequences are among the major public health problems in the world. Unfortunately, the therapeutic efficacies of present strategies are still unsatisfactory with a major concern about viral mutation. In search of effective antiviral agent, we examined the efficacy of extracts of Polygonum cuspidatum Sieb. et Zucc. (P. cuspidatum) against HBV in HepG(2) 2.2.15 cells by quantitative real time polymerase chain reaction. The expressions of viral antigens, HBeAg and HBsAg, were also determined by enzyme linked immunosorbent assay. The ethanol extract of P. cuspidatum could inhibit dose-dependently the production of HBV (p < 0.0001) with all effective minimal dosage of 10 mu g/ml. The water extract of P. cuspidatum might also inhibit the production of HBV at a higher dosage. The expression of HBsAg was significantly increased by both ethanol extract and water extract of P. cuspidatum dose-dependently (p < 0.0001) and time-dependently (p < 0.0001). Higher dose of water extract of P. cuspidatum (30 mu g/ml) could inhibit the expression of HBeAg (p < 0.05). The extract of P. cuspidatum might contain compounds that would contribute to the control of HBV infection ill the future. However, its promoting effect on the expression of HBsAg and its cytotoxicity should be monitored. Further purification of the active compounds, identification and modification of their structures to improve the efficacy and decrease the cytotoxicity are required. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 39 条
  • [1] INVITRO VIRUCIDAL ACTIVITY OF SELECTED ANTHRAQUINONES AND ANTHRAQUINONE DERIVATIVES
    ANDERSEN, DO
    WEBER, ND
    WOOD, SG
    HUGHES, BG
    MURRAY, BK
    NORTH, JA
    [J]. ANTIVIRAL RESEARCH, 1991, 16 (02) : 185 - 196
  • [2] Ayoola E. A., 1988, Bull. World Health Org, V66, P443
  • [3] Banerjee S, 2002, CANCER RES, V62, P4945
  • [4] EVALUATION OF THE ANTIVIRAL ACTIVITY OF ANTHRAQUINONES, ANTHRONES AND ANTHRAQUINONE DERIVATIVES AGAINST HUMAN CYTOMEGALOVIRUS
    BARNARD, DL
    HUFFMAN, JH
    MORRIS, JLB
    WOOD, SG
    HUGHES, BG
    SIDWELL, RW
    [J]. ANTIVIRAL RESEARCH, 1992, 17 (01) : 63 - 77
  • [5] BEASLEY RP, 1981, LANCET, V2, P1129
  • [6] Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients
    Benhamou, Y
    Bochet, M
    Thibault, V
    Di Martino, V
    Caumes, E
    Bricaire, F
    Opolon, P
    Katlama, C
    Poynard, T
    [J]. HEPATOLOGY, 1999, 30 (05) : 1302 - 1306
  • [7] Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a
    Carreño, V
    Marcellin, P
    Hadziyannis, S
    Salmerón, J
    Diago, M
    Kitis, GE
    Vafiadis, I
    Schalm, SW
    Zahm, F
    Manzarbeitia, F
    Jiménez, FJ
    Quiroga, JA
    [J]. HEPATOLOGY, 1999, 30 (01) : 277 - 282
  • [8] Real-time PCR for detection and quantitation of hepatitis B virus DNA
    Chen, RW
    Piiparinen, H
    Seppänen, M
    Koskela, P
    Sarna, S
    Lappalainen, M
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (02) : 250 - 256
  • [9] CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333
  • [10] Antiviral activities of anthraquinones, bianthrones and hypericin derivatives from lichens
    Cohen, PA
    Hudson, JB
    Towers, GHN
    [J]. EXPERIENTIA, 1996, 52 (02): : 180 - 183